TIMBERLYN BEAL: Open Payments
NPI 1932551850 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 18 payments from 8 companies in 2025. Trend: 2023 $818 · 2024 $758 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $350 |
| Novo Nordisk Inc | 8 | $320 |
| Abbott Laboratories | 1 | $25 |
| Insulet Corporation | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
Products named: BREZTRI, Ozempic, FARXIGA, FREESTYLE LIBRE 3, Omnipod, GVOKE HYPOPEN, Kerendia, Rybelsus.
Industry payments across TN — which companies pay providers there.
